Premium
Relative Bioavailability of Lamotrigine Chewable Dispersible Tablets Administered Rectally
Author(s) -
Birnbaum Angela K.,
Kriel Robert L.,
Im Yoonsun,
Remmel Rory P.
Publication year - 2001
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.21.2.158.34104
Subject(s) - bioavailability , rectal administration , medicine , pharmacology , pharmacokinetics , dosing , dosage form , oral administration , drug , crossover study , alternative medicine , pathology , placebo
Study Objective. To determine the relative bioavailability of lamotrigine (LTG) chewable dispersible tablets after rectal administration. Design. Two‐period, crossover study with a 2‐week washout between dosing periods. Setting. Clinical research center. Patients. Twelve healthy adult volunteers. Intervention. One hundred milligrams of a LTG chewable dispersible tablet was administered by oral and rectal routes. Measurements and Main Results. Plasma samples were collected before and up to 120 hours after drug administration. The samples were analyzed for LTG by high‐performance liquid chromatography, and the relative bioavailability was determined. Drug concentrations were lower after rectal than after oral administration. The relative bioavailability (F = AUC rectal /AUC oral ) was 0.52 ± 0.23 (SD). Conclusion. Drug prepared from LTG chewable dispersible tablets is absorbed rectally, although not to the same extent as when given orally. Rectal administration of suspension of these tablets can be an acceptable route of administration.